Sökning: "Bleeding disorders"
Visar resultat 1 - 5 av 35 avhandlingar innehållade orden Bleeding disorders.
1. Genetic Screening in Patients Suspected of Inherited Bleeding Disorders
Sammanfattning : Inherited bleeding disorders constitute a heterogeneous group of genetic diseases, affecting virtually all major components of the hemostatic system. The diagnostics are potentially complex, and a high proportion of patients remain without a conclusive diagnosis following work-up. LÄS MER
2. Astheno-emotional disorder after aneurysmal subarachnoid hemorrhage. Classification, outcome, and relation to anxiety and depressive disorders
Sammanfattning : Background: Psychiatric symptoms such as fatigue, concentration and memory difficulties, anxiety, and depressiveness are frequently reported after aneurysmal subarachnoid hemorrhage (aSAH) and in various other neurological diseases. These symptoms may indicate the presence of organic psychiatric disorders (OPDs), such as the Astheno-Emotional (AE-) disorder, of anxiety or depressive disorders, or both, but psychiatric classification and differentiation between such disorders have seldom been used in follow-up studies of neurological disease. LÄS MER
3. Bleeding tendency and health-related quality of life in carriers of haemophilia
Sammanfattning : Haemophilia A and B are X-linked disorders caused by impaired synthesis of coagulation factors VIII and IX, respectively. Women who carry the haemophilia trait have about 50 % of normal factor levels. LÄS MER
4. Platelet transfusions in hematological disorders
Sammanfattning : Platelets are important for clot formation and vascular integrity. Thrombocytopenic patients with hematological disorders are at risk of bleeding and platelet transfusions are important in supportive care and treatment of lite-threatening bleedings. LÄS MER
5. Haemophilia B - Diagnostic Insights, Genetic Aspects and Clinical Outcomes
Sammanfattning : Haemophilia B (HB) is a rare inherited bleeding disorder caused by the deficiency of coagulation factor IX (FIX). The major clinical issues are bleedings, often targeting the joints, and the development of neutralising antibodies, i.e. inhibitors, to the FIX replacement therapy. LÄS MER